Works matching IS 08876924 AND DT 2013 AND VI 27 AND IP 12

Results: 30

Galectin-3 in pre-B acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2385, doi. 10.1038/leu.2013.175

By:

Fei, F;
Abdel-Azim, H;
Lim, M;
Arutyunyan, A;
von Itzstein, M;
Groffen, J;
Heisterkamp, N

Publication type:

Article

A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2301, doi. 10.1038/leu.2013.83

By:

Caldarelli, A;
Müller, J P;
Paskowski-Rogacz, M;
Herrmann, K;
Bauer, R;
Koch, S;
Heninger, A K;
Krastev, D;
Ding, L;
Kasper, S;
Fischer, T;
Brodhun, M;
Böhmer, F-D;
Buchholz, F

Publication type:

Article

A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signaling.

Published in:

2013

By:

Caldarelli, A;
Müller, J P;
Paskowski-Rogacz, M;
Herrmann, K;
Bauer, R;
Koch, S;
Heninger, A K;
Krastev, D;
Ding, L;
Kasper, S;
Fischer, T;
Brodhun, M;
Böhmer, F-D;
Buchholz, F

Publication type:

journal article

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.

Published in:

2013

By:

Karpova, D;
Dauber, K;
Spohn, G;
Chudziak, D;
Wiercinska, E;
Schulz, M;
Pettit, A R;
Levesque, J P;
Romagnoli, B;
Patel, K;
Chevalier, E;
Dembowsky, K;
Bonig, H

Publication type:

journal article

Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2413, doi. 10.1038/leu.2013.153

By:

Tomizawa, D;
Tawa, A;
Watanabe, T;
Saito, A M;
Kudo, K;
Taga, T;
Iwamoto, S;
Shimada, A;
Terui, K;
Moritake, H;
Kinoshita, A;
Takahashi, H;
Nakayama, H;
Koh, K;
Kigasawa, H;
Kosaka, Y;
Miyachi, H;
Horibe, K;
Nakahata, T;
Adachi, S

Publication type:

Article

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.

Published in:

2013

By:

Zhao, X;
Lwin, T;
Zhang, X;
Huang, A;
Wang, J;
Marquez, V E;
Chen-Kiang, S;
Dalton, W S;
Sotomayor, E;
Tao, J

Publication type:

journal article

Prognostic impact and landscape of NOTCH1 mutations in chronic lymphocytic leukemia (CLL): a study on 852 patients.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2393, doi. 10.1038/leu.2013.218

By:

Weissmann, S;
Roller, A;
Jeromin, S;
Hernández, M;
Abáigar, M;
Hernández-Rivas, J M;
Grossmann, V;
Haferlach, C;
Kern, W;
Haferlach, T;
Schnittger, S;
Kohlmann, A

Publication type:

Article

Imatinib results in better outcomes than HLA-identical sibling transplants in young persons with newly diagnosed chronic-phase chronic myelogenous leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2410, doi. 10.1038/leu.2013.159

By:

Jiang, Q;
Xu, L-P;
Liu, D-H;
Liu, K-Y;
Gale, R P;
Zhang, M-J;
Jiang, B;
Zhang, X-H;
Wang, Y;
Chen, S-S;
Zhao, X-Y;
Chen, H;
Jiang, H;
Chen, Y-H;
Han, W;
Qin, Y-Z;
Liu, Y-R;
Lai, Y-Y;
Lv, M;
Huang, X-J

Publication type:

Article

Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2379, doi. 10.1038/leu.2013.147

By:

Bernot, K M;
Siebenaler, R F;
Whitman, S P;
Zorko, N A;
Marcucci, G G;
Santhanam, R;
Ahmed, E H;
Ngangana, M;
McConnell, K K;
Nemer, J S;
Brook, D L;
Kulp, S K;
Chen, C S;
Frankhouser, D;
Yan, P;
Bundschuh, R;
Zhang, X;
Dorrance, A M;
Dickerson, K E;
Jarjoura, D

Publication type:

Article

In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2404, doi. 10.1038/leu.2013.203

By:

Strullu, M;
Caye, A;
Cassinat, B;
Fenneteau, O;
Touzot, F;
Blauwblomme, T;
Rodriguez, R;
Latour, S;
Petit, A;
Barlogis, V;
Galambrun, C;
Leblanc, T;
Baruchel, A;
Chomienne, C;
Cavé, H

Publication type:

Article

Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2407, doi. 10.1038/leu.2013.164

By:

Mehta, H M;
Glaubach, T;
Long, A;
Lu, H;
Przychodzen, B;
Makishima, H;
McDevitt, M A;
Cross, N C P;
Maciejewski, J;
Corey, S J

Publication type:

Article

Aberrant expression of CCR4 in diffuse large B-cell lymphoma, not otherwise specified.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2382, doi. 10.1038/leu.2013.128

By:

Nakayama, S;
Yokote, T;
Hirata, Y;
Iwaki, K;
Akioka, T;
Miyoshi, T;
Hiraoka, N;
Takayama, A;
Nishiwaki, U;
Masuda, Y;
Nishimura, Y;
Tsuji, M;
Hanafusa, T

Publication type:

Article

Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2341, doi. 10.1038/leu.2013.94

By:

Zhao, X;
Lwin, T;
Zhang, X;
Huang, A;
Wang, J;
Marquez, V E;
Chen-Kiang, S;
Dalton, W S;
Sotomayor, E;
Tao, J

Publication type:

Article

Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2376, doi. 10.1038/leu.2013.127

By:

Bassaganyas, L;
Beà, S;
Escaramís, G;
Tornador, C;
Salaverria, I;
Zapata, L;
Drechsel, O;
Ferreira, P G;
Rodriguez-Santiago, B;
Tubio, J M C;
Navarro, A;
Martín-García, D;
López, C;
Martínez-Trillos, A;
López-Guillermo, A;
Gut, M;
Ossowski, S;
López-Otín, C;
Campo, E;
Estivill, X

Publication type:

Article

Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2419, doi. 10.1038/leu.2013.149

By:

Lo Nigro, L;
Mirabile, E;
Tumino, M;
Caserta, C;
Cazzaniga, G;
Rizzari, C;
Silvestri, D;
Buldini, B;
Barisone, E;
Casale, F;
Luciani, M;
Locatelli, F;
Messina, C;
Micalizzi, C;
Pession, A;
Parasole, R;
Santoro, N;
Masera, G;
Basso, G;
Aricò, M

Publication type:

Article

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2322, doi. 10.1038/leu.2013.266

By:

Karpova, D;
Dauber, K;
Spohn, G;
Chudziak, D;
Wiercinska, E;
Schulz, M;
Pettit, A R;
Levesque, J P;
Romagnoli, B;
Patel, K;
Chevalier, E;
Dembowsky, K;
Bonig, H

Publication type:

Article

Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2351, doi. 10.1038/leu.2013.152

By:

Jakubowiak, A J;
Siegel, D S;
Martin, T;
Wang, M;
Vij, R;
Lonial, S;
Trudel, S;
Kukreti, V;
Bahlis, N;
Alsina, M;
Chanan-Khan, A;
Buadi, F;
Reu, F J;
Somlo, G;
Zonder, J;
Song, K;
Stewart, A K;
Stadtmauer, E;
Harrison, B L;
Wong, A F

Publication type:

Article

Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2289, doi. 10.1038/leu.2013.156

By:

Gachet, S;
Genescà, E;
Passaro, D;
Irigoyen, M;
Alcalde, H;
Clémenson, C;
Poglio, S;
Pflumio, F;
Janin, A;
Lasgi, C;
Dodier, S;
Soyer, M;
Duménil, G;
Ghysdael, J

Publication type:

Article

Understanding the interplay between the proteasome pathway and autophagy in response to dual PI3K/mTOR inhibition in myeloma cells is essential for their effective clinical application.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2397, doi. 10.1038/leu.2013.150

By:

Aronson, L I;
Davenport, E L;
Mirabella, F;
Morgan, G J;
Davies, F E

Publication type:

Article

Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: incidence and prognostic significance.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2422, doi. 10.1038/leu.2013.126

By:

Zamarin, D;
Devlin, S M;
Arcila, M E;
Landau, H;
Lesokhin, A;
Lendvai, N;
Chung, D J;
Chimento, D;
Weltz, J;
Babu, D;
Giralt, S;
Hassoun, H

Publication type:

Article

Functional characterization of Foxp3-specific spontaneous immune responses.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2332, doi. 10.1038/leu.2013.196

By:

Larsen, S K;
Munir, S;
Woetmann, A;
Frøsig, T M;
Odum, N;
Svane, I M;
Becker, J C;
Andersen, M H

Publication type:

Article

Vertebral augmentation in the treatment of pathologic compression fractures in 792 patients with multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2391, doi. 10.1038/leu.2013.162

By:

Erdem, E;
Samant, R;
Malak, S F;
Culp, W C;
Brown, A;
Peterson, L;
Lensing, S;
Barlogie, B

Publication type:

Article

NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2280, doi. 10.1038/leu.2013.87

By:

de Rooij, J D E;
Hollink, I H I M;
Arentsen-Peters, S T C J M;
van Galen, J F;
Berna Beverloo, H;
Baruchel, A;
Trka, J;
Reinhardt, D;
Sonneveld, E;
Zimmermann, M;
Alonzo, T A;
Pieters, R;
Meshinchi, S;
van den Heuvel-Eibrink, M M;
Zwaan, C Michel

Publication type:

Article

JAK inhibitors suppress t(8;21) fusion protein-induced leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2272, doi. 10.1038/leu.2013.197

By:

Lo, M-C;
Peterson, L F;
Yan, M;
Cong, X;
Hickman, J H;
DeKelver, R C;
Niewerth, D;
Zhang, D-E

Publication type:

Article

SOX11 overexpression is a specific marker for mantle cell lymphoma and correlates with t(11;14) translocation, CCND1 expression and an adverse prognosis.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2388, doi. 10.1038/leu.2013.141

By:

Meggendorfer, M;
Kern, W;
Haferlach, C;
Haferlach, T;
Schnittger, S

Publication type:

Article

Genome-wide studies in multiple myeloma identify XPO1/CRM1 as a critical target validated using the selective nuclear export inhibitor KPT-276.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2357, doi. 10.1038/leu.2013.172

By:

Schmidt, J;
Braggio, E;
Kortuem, K M;
Egan, J B;
Zhu, Y X;
Xin, C S;
Tiedemann, R E;
Palmer, S E;
Garbitt, V M;
McCauley, D;
Kauffman, M;
Shacham, S;
Chesi, M;
Bergsagel, P L;
Stewart, A K

Publication type:

Article

Heterogeneity of outcome with single-agent carfilzomib: all relapsed/refractory myelomas are not created equal.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2269, doi. 10.1038/leu.2013.161

By:

Usmani, S Z;
Hoering, A

Publication type:

Article

Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2366, doi. 10.1038/leu.2013.194

By:

Cirstea, D;
Hideshima, T;
Santo, L;
Eda, H;
Mishima, Y;
Nemani, N;
Hu, Y;
Mimura, N;
Cottini, F;
Gorgun, G;
Ohguchi, H;
Suzuki, R;
Loferer, H;
Munshi, N C;
Anderson, K C;
Raje, N

Publication type:

Article

Associations between genome-wide Native American ancestry, known risk alleles and B-cell ALL risk in Hispanic children.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2416, doi. 10.1038/leu.2013.130

By:

Walsh, K M;
Chokkalingam, A P;
Hsu, L-I;
Metayer, C;
de Smith, A J;
Jacobs, D I;
Dahl, G V;
Loh, M L;
Smirnov, I V;
Bartley, K;
Ma, X;
Wiencke, J K;
Barcellos, L F;
Wiemels, J L;
Buffler, P A

Publication type:

Article

Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy.

Published in:

Leukemia (08876924), 2013, v. 27, n. 12, p. 2311, doi. 10.1038/leu.2013.131

By:

Herman, S E M;
Sun, X;
McAuley, E M;
Hsieh, M M;
Pittaluga, S;
Raffeld, M;
Liu, D;
Keyvanfar, K;
Chapman, C M;
Chen, J;
Buggy, J J;
Aue, G;
Tisdale, J F;
Pérez-Galán, P;
Wiestner, A

Publication type:

Article